These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22553667)

  • 21. Lutein, zeaxanthin and meso-zeaxanthin content of eggs laid by hens supplemented with free and esterified xanthophylls.
    Nolan JM; Meagher KA; Howard AN; Moran R; Thurnham DI; Beatty S
    J Nutr Sci; 2016; 5():e1. PubMed ID: 26793307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of macular xanthophyll supplementation on brain-derived neurotrophic factor, pro-inflammatory cytokines, and cognitive performance.
    Stringham NT; Holmes PV; Stringham JM
    Physiol Behav; 2019 Nov; 211():112650. PubMed ID: 31425700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dietary modulation of lens zeaxanthin in quail.
    Dorey CK; Granata L; Nichols CR; Cheng KM; Craft NE
    Exp Eye Res; 2005 Oct; 81(4):464-77. PubMed ID: 15913607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic ingestion of (3R,3'R,6'R)-lutein and (3R,3'R)-zeaxanthin in the female rhesus macaque.
    Khachik F; London E; de Moura FF; Johnson M; Steidl S; Detolla L; Shipley S; Sanchez R; Chen XQ; Flaws J; Lutty G; McLeod S; Fowler B
    Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5476-86. PubMed ID: 17122139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973.
    Richer SP; Stiles W; Graham-Hoffman K; Levin M; Ruskin D; Wrobel J; Park DW; Thomas C
    Optometry; 2011 Nov; 82(11):667-680.e6. PubMed ID: 22027699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enrichment of Macular Pigment Enhances Contrast Sensitivity in Subjects Free of Retinal Disease: Central Retinal Enrichment Supplementation Trials - Report 1.
    Nolan JM; Power R; Stringham J; Dennison J; Stack J; Kelly D; Moran R; Akuffo KO; Corcoran L; Beatty S
    Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3429-39. PubMed ID: 27367585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Results of the use of antioxidant and angioprotective agents in type 2 diabetes patients with diabetic retinopathy and age-related macular degeneration].
    Moshetova LK; Vorob'eva IV; Alekseev IB; Mikhaleva LG
    Vestn Oftalmol; 2015; 131(3):34-44. PubMed ID: 26310005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of macular pigment and contrast threshold in Spanish healthy normolipemic subjects (45-65 years) with habitual food intake.
    Olmedilla-Alonso B; Rodríguez-Rodríguez E; Beltrán-de-Miguel B; Estévez-Santiago R; Sánchez-Prieto M
    PLoS One; 2021; 16(5):e0251324. PubMed ID: 34043644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of lutein supplementation on visual function in nonproliferative diabetic retinopathy.
    Zhang PC; Wu CR; Wang ZL; Wang LY; Han Y; Sun SL; Li QS; Ma L
    Asia Pac J Clin Nutr; 2017 May; 26(3):406-411. PubMed ID: 28429904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of supplemental lutein and zeaxanthin on serum, macular pigmentation, and visual performance in patients with early age-related macular degeneration.
    Huang YM; Dou HL; Huang FF; Xu XR; Zou ZY; Lin XM
    Biomed Res Int; 2015; 2015():564738. PubMed ID: 25815324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Xanthophyll accumulation in the human retina during supplementation with lutein or zeaxanthin - the LUXEA (LUtein Xanthophyll Eye Accumulation) study.
    Schalch W; Cohn W; Barker FM; Köpcke W; Mellerio J; Bird AC; Robson AG; Fitzke FF; van Kuijk FJ
    Arch Biochem Biophys; 2007 Feb; 458(2):128-35. PubMed ID: 17084803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of dietary zeaxanthin on tissue distribution of zeaxanthin and lutein in quail.
    Toyoda Y; Thomson LR; Langner A; Craft NE; Garnett KM; Nichols CR; Cheng KM; Dorey CK
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1210-21. PubMed ID: 11923268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lutein and zeaxanthin supplementation and association with visual function in age-related macular degeneration.
    Liu R; Wang T; Zhang B; Qin L; Wu C; Li Q; Ma L
    Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):252-8. PubMed ID: 25515572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ocular Effects of Prenatal Carotenoid Supplementation in the Mother and Her Child: The Lutein and Zeaxanthin in Pregnancy (L-ZIP) Randomized Trial - Report Number 2.
    Addo EK; Gorka JE; Allman SJ; Harrison DY; Sharifzadeh M; Hoffman RO; Hartnett ME; Varner MW; Bernstein PS
    Ophthalmol Sci; 2024; 4(5):100537. PubMed ID: 39071916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Superior Bioavailability of a Novel Lutein and Zeaxanthin Formulation in Healthy Human Subjects.
    Kotagiri SR; Morde A; Rai D; Babji K; Lal M; Padigaru M; Khatri C
    Ophthalmol Ther; 2022 Aug; 11(4):1463-1477. PubMed ID: 35585428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lutein and zeaxanthin measured separately in the living human retina with fundus reflectometry.
    van de Kraats J; Kanis MJ; Genders SW; van Norren D
    Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5568-73. PubMed ID: 18676627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of macular xanthophylls in prevention of common neovascular retinopathies: retinopathy of prematurity and diabetic retinopathy.
    Gong X; Rubin LP
    Arch Biochem Biophys; 2015 Apr; 572():40-48. PubMed ID: 25701588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Supplementation with three different macular carotenoid formulations in patients with early age-related macular degeneration.
    Sabour-Pickett S; Beatty S; Connolly E; Loughman J; Stack J; Howard A; Klein R; Klein BE; Meuer SM; Myers CE; Akuffo KO; Nolan JM
    Retina; 2014 Sep; 34(9):1757-66. PubMed ID: 24887490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The macular pigment: short- and intermediate-term changes of macular pigment optical density following supplementation with lutein and zeaxanthin and co-antioxidants. The LUNA Study].
    Zeimer M; Hense HW; Heimes B; Austermann U; Fobker M; Pauleikhoff D
    Ophthalmologe; 2009 Jan; 106(1):29-36. PubMed ID: 18551295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lutein and zeaxanthin in the eyes, serum and diet of human subjects.
    Bone RA; Landrum JT; Dixon Z; Chen Y; Llerena CM
    Exp Eye Res; 2000 Sep; 71(3):239-45. PubMed ID: 10973733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.